BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17998148)

  • 1. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
    Zimmermann M; Flechsig C; La Monica N; Tripodi M; Adler G; Dikopoulos N
    J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases.
    Shi Y; Du L; Lv D; Li Y; Zhang Z; Huang X; Tang H
    J Gastroenterol; 2021 Apr; 56(4):336-349. PubMed ID: 33665710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized Mouse Models for the Study of Hepatitis C and Host Interactions.
    Yong KSM; Her Z; Chen Q
    Cells; 2019 Jun; 8(6):. PubMed ID: 31213010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.
    Chigbu DI; Loonawat R; Sehgal M; Patel D; Jain P
    Cells; 2019 Apr; 8(4):. PubMed ID: 31027278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to Circumvent Host Innate Immune Response by Hepatitis C Virus.
    Patra T; Ray RB; Ray R
    Cells; 2019 Mar; 8(3):. PubMed ID: 30909456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication.
    Eisenreich W; Rudel T; Heesemann J; Goebel W
    Front Cell Infect Microbiol; 2019; 9():42. PubMed ID: 30886834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection.
    Hartlage AS; Murthy S; Kumar A; Trivedi S; Dravid P; Sharma H; Walker CM; Kapoor A
    Nat Commun; 2019 Mar; 10(1):1113. PubMed ID: 30846697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of Hepatitis C Virus Infection.
    Kaplan DE
    Gastroenterol Clin North Am; 2015 Dec; 44(4):735-60. PubMed ID: 26600217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.
    Longley RJ; Bauza K; Ewer KJ; Hill AV; Spencer AJ
    PLoS One; 2015; 10(3):e0119880. PubMed ID: 25822951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?
    Sehgal M; Khan ZK; Talal AH; Jain P
    Virology (Auckl); 2013; 4():1-25. PubMed ID: 25512691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells.
    Rana D; Chawla Y; Arora SK
    Indian J Med Res; 2013 Nov; 138(5):766-78. PubMed ID: 24434330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of the functional states of dendritic cells under different conditioned microenvironments by Fourier transformed infrared spectroscopy.
    Dong R; Long J; Xu X; Zhang C; Wen Z; Li L; Yao W; Zeng Z
    Biomed Eng Online; 2014 Jan; 13():2. PubMed ID: 24410930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral proteome size and CD8+ T cell epitope density are correlated: the effect of complexity on selection.
    Agranovich A; Maman Y; Louzoun Y
    Infect Genet Evol; 2013 Dec; 20():71-7. PubMed ID: 23954420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic ethanol diet increases regulatory T-cell activity and inhibits hepatitis C virus core-specific cellular immune responses in mice.
    Ortiz V; Wands JR
    Hepatol Res; 2014 Jul; 44(7):788-97. PubMed ID: 23710581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV J6/JFH1 tilts the capability of myeloid-derived dendritic cells to favor the induction of immunosuppression and Th17-related inflammatory cytokines.
    Fang Z; Zhu K; Guo N; Zhang N; Guan M; Yang C; Pan Q; Wei R; Yang C; Deng C; Liu X; Zhao P; Leng Q
    Pharm Res; 2015 Mar; 32(3):741-8. PubMed ID: 23619596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposes.
    Hosseini SY; Sabahi F; Moazzeni SM; Modarressi MH; Saberi Firoozi M; Ravanshad M
    Hepat Mon; 2012 Aug; 12(8):e6130. PubMed ID: 23087750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
    Zhu W; Wu C; Deng W; Pei R; Wang Y; Cao L; Qin B; Lu M; Chen X
    PLoS One; 2012; 7(9):e45146. PubMed ID: 23024803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface.
    Kim H; Mazumdar B; Bose SK; Meyer K; Di Bisceglie AM; Hoft DF; Ray R
    J Virol; 2012 Sep; 86(18):9919-28. PubMed ID: 22761382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for liver tumors: present status and future prospects.
    Matar P; Alaniz L; Rozados V; Aquino JB; Malvicini M; Atorrasagasti C; Gidekel M; Silva M; Scharovsky OG; Mazzolini G
    J Biomed Sci; 2009 Mar; 16(1):30. PubMed ID: 19272130
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.